Cargando…
Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient
Background: Cystic fibrosis (CF) is caused by a wide spectrum of mutations in the CF transmembrane conductance regulator (CFTR) gene, with some leading to non-classical clinical presentations. We present an integrated in vivo, in silico and in vitro investigation of an individual with CF carrying th...
Autores principales: | Allan, Katelin M., Astore, Miro A., Kardia, Egi, Wong, Sharon L., Fawcett, Laura K., Bell, Jessica L., Visser, Simone, Chen, Po-Chia, Griffith, Renate, Jaffe, Adam, Sivam, Sheila, Vittorio, Orazio, Kuyucak, Serdar, Waters, Shafagh A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267335/ https://www.ncbi.nlm.nih.gov/pubmed/37325471 http://dx.doi.org/10.3389/fmolb.2023.1148501 |
Ejemplares similares
-
Elexacaftor/tezacaftor/ivacaftor for cystic fibrosis
Publicado: (2021) -
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
por: Veit, Guido, et al.
Publicado: (2020) -
Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype
por: Comegna, Marika, et al.
Publicado: (2021) -
Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect
por: Wong, Sharon L., et al.
Publicado: (2022) -
S945L-CFTR molecular dynamics, functional characterization and tezacaftor/ivacaftor efficacy in vivo and in vitro in matched pediatric patient-derived cell models
por: Allan, Katelin M., et al.
Publicado: (2022)